SCHEMBL22556946

SCHEMBL22556946

O=[N+]([O-])c1cc(S(F)(F)(F)(F)F)cc(Cl)c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 8/20 0.59
ALDH1A1 P00352 5/20 0.41
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 3/20 0.41
MAPT P10636 3/20 0.41
KMT2A Q03164 3/20 0.41
TTR P02766 2/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 2/20 0.41
HIF1A Q16665 2/20 0.41
MAPK1 P28482 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX12 P18054 1/20 0.41
RECQL P46063 1/20 0.41
PMP22 Q01453 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PKM P14618 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL103341 0.77 GPR35 (0.65) GPR35ALDH1A1CYP3A4TDP1KDM4E
SCHEMBL1024025 0.76 CYP3A4 (0.66) GPR35ALDH1A1CYP3A4TDP1MEN1
SCHEMBL310420 0.76 GPR35 (0.69) GPR35ALDH1A1CYP3A4TDP1KDM4E
SCHEMBL18607548 0.75 VCAM1 (0.51) TDP1MAPTMAPK1TSHR
SCHEMBL2165473 0.74 GPR35 (1.00) GPR35ALDH1A1CYP3A4TDP1KDM4E
SCHEMBL30807397 0.74 GPR35 (1.00) GPR35ALDH1A1CYP3A4TDP1KDM4E
SCHEMBL8023115 0.74 TDP1 (0.41) GPR35ALDH1A1CYP3A4TDP1MEN1
SCHEMBL4544555 0.73 GPR35 (0.74) GPR35ALDH1A1CYP3A4TDP1KDM4E
SCHEMBL4293562 0.73 GPR35 (0.65) GPR35ALDH1A1CYP3A4TDP1KDM4E
SCHEMBL28325905 0.73 GPR35 (0.65) GPR35ALDH1A1CYP3A4TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384769-B2 Heteroaryl-substituted aminoalkyl azole compounds as pesticides ELANCO ANIMAL HEALTH GMBH (DE) 2025-08-12 US disclosed
CN-113939509-B Novel heteroaryl substituted aminoalkylazole compounds as pesticides 拜耳动物保健有限责任公司 2024-11-29 CN disclosed
US-20230046680-A1 NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-02-16 US disclosed
EP-3956325-A1 NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES Bayer Animal Health GmbH (DE) 2022-02-23 EP disclosed
WO-2020212235-A1 NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES BAYER ANIMAL HEALTH GMBH (DE) 2020-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230046680-A1 NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES DDT, CRY1, CYP4F3 GPR35 815/4885ALDH1A1 3433/4885CYP3A4 92/4885
US-12384769-B2 Heteroaryl-substituted aminoalkyl azole compounds as pesticides DDT, CRY1, AAAS GPR35 767/4885ALDH1A1 3552/4885CYP3A4 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.